Hsiu-Ju Yen

6PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyMedical virologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2026
A Phase Ib Case Series Using Bortezomib With Chemotherapy in Atypical Teratoid/Rhabdoid Tumors.

|Feb 20, 2026
Low flow cytometry events in detecting CNS involvement in pediatric B-cell precursor ALL: NGS validation and prognostic significance.

Shu-Wei Chou, Ying-Hui Su, Meng-Yao Lu

|May 04, 2023
A case series and literature review on 98 pediatric patients of germ cell tumor developing growing teratoma syndrome.

Ming-Yun Hsieh, Hsin-Hung Chen, Chih-Ying Lee

|Jul 05, 2022
Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.

Fu-Shiuan Whitney Lee, Chih-Ying Lee, Giun-Yi Hung

|Mar 01, 2021
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma.

Hsin-Lien Tsai, Yi-Chen Yeh, Ting-Yen Yu

|Feb 01, 2021
RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions.

Ying-Jung Huang, Hsi-Che Liu, Tang-Her Jaing

Pageof 1

Frequent Collaborators

2 joint publications

Pei-Chin Lin

2 joint publications

Giun-Yi Hung

1 joint publications

Tang-Her Jaing

1 joint publications

Shih-Hsiang Chen